At the end of the latest market close, Arrowhead Pharmaceuticals Inc. (ARWR) was valued at $42.24. In that particular session, Stock kicked-off at the price of $41.88 while reaching the peak value of $42.74 and lowest value recorded on the day was $38.89. The stock current value is $39.00.
Recently in News on August 31, 2020, Arrowhead Presents Positive New Phase 1/2 Clinical Data on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3 at European Society of Cardiology Congress 2020. Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced the presentation of positive new Phase 1/2 clinical data on two RNAi-based cardiometabolic candidates, ARO-APOC3 targeting apolipoprotein C-III (APOC3) being developed as a treatment for patients with hypertriglyceridemia, and ARO-ANG3 targeting angiopoietin like protein 3 (ANGPTL3) being developed as a treatment for mixed dyslipidemias. The data were presented in back-to-back oral presentations at the European Society of Cardiology (ESC) Congress 2020. You can read further details here
Arrowhead Pharmaceuticals Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $64.00 on 01/02/20, with the lowest value was $19.51 for the same time period, recorded on 03/18/20.
Arrowhead Pharmaceuticals Inc. (ARWR) full year performance was 17.36%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Arrowhead Pharmaceuticals Inc. shares are logging -47.10% during the 52-week period from high price, and 99.90% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $19.51 and $73.72.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1494205 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Arrowhead Pharmaceuticals Inc. (ARWR) recorded performance in the market was -38.51%, having the revenues showcasing 21.84% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 3.98B, as it employees total of 134 workers.
Arrowhead Pharmaceuticals Inc. (ARWR) in the eye of market guru’s
During the last month, 0 analysts gave the Arrowhead Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 39.75, with a change in the price was noted +5.13. In a similar fashion, Arrowhead Pharmaceuticals Inc. posted a movement of +15.15% for the period of last 100 days, recording 1,098,614 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ARWR is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Arrowhead Pharmaceuticals Inc. (ARWR): Stocks Technical analysis and Trends
Raw Stochastic average of Arrowhead Pharmaceuticals Inc. in the period of last 50 days is set at 5.04%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 1.44%. In the last 20 days, the company’s Stochastic %K was 24.79% and its Stochastic %D was recorded 31.93%.
If we look into the earlier routines of Arrowhead Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -38.51%. Additionally, trading for the stock in the period of the last six months notably improved by 5.61%, alongside a boost of 17.36% for the period of the last 12 months. The shares increased approximately by -9.99% in the 7-day charts and went up by -12.12% in the period of the last 30 days. Common stock shares were driven by 21.84% during last recorded quarter.